The export of vaccines for human use from Austria stood at 241.23 million USD in 2023. Forecasted data indicate a year-on-year increase with the following values: 246.84 million USD in 2024 (2.32% YoY), 251.45 million USD in 2025 (1.87% YoY), 255.97 million USD in 2026 (1.80% YoY), 260.39 million USD in 2027 (1.73% YoY), and 264.74 million USD in 2028 (1.67% YoY). The compound annual growth rate (CAGR) over the five-year period from 2023 to 2028 is approximately 1.88%.
Future trends to watch for include advancements in vaccine technology, shifts in global health policies, and potential fluctuations in international demand due to emerging diseases or pandemic preparedness measures. Monitoring these factors could provide insights into further growth potential or challenges in the vaccine export market from Austria.
Latest reports
US Vaccine Market Report- Q1 2025
The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...
China Vaccine Market Report- Q1 2025
The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...
Japan Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...
Germany Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...
India Vaccine Market Report- Q4 2024
The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...
UK Vaccine Market Report- Q4 2024
The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...
France Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...
Canada Vaccine Market Report- Q4 2024
The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...
Brazil Vaccine Market Report- Q4 2024
The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...
Italy Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...
